These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bovine deciduous dentine is more susceptible to osteoclastic resorption than permanent dentine: results of quantitative analyses. Varghese BJ; Aoki K; Shimokawa H; Ohya K; Takagi Y J Bone Miner Metab; 2006; 24(3):248-54. PubMed ID: 16622739 [TBL] [Abstract][Full Text] [Related]
3. Polarized osteoclasts put marks of tartrate-resistant acid phosphatase on dentin slices--a simple method for identifying polarized osteoclasts. Nakayama T; Mizoguchi T; Uehara S; Yamashita T; Kawahara I; Kobayashi Y; Moriyama Y; Kurihara S; Sahara N; Ozawa H; Udagawa N; Takahashi N Bone; 2011 Dec; 49(6):1331-9. PubMed ID: 21983021 [TBL] [Abstract][Full Text] [Related]
4. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity. Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630 [TBL] [Abstract][Full Text] [Related]
5. A novel osteoclast precursor cell line, 4B12, recapitulates the features of primary osteoclast differentiation and function: enhanced transfection efficiency before and after differentiation. Amano S; Sekine K; Bonewald LF; Ohmori Y J Cell Physiol; 2009 Oct; 221(1):40-53. PubMed ID: 19492422 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the ability of chondroitin sulfate derived from bovine, fish and pigs to suppress human osteoclast activity in vitro. Cantley MD; Rainsford KD; Haynes DR Inflammopharmacology; 2013 Dec; 21(6):407-12. PubMed ID: 23644893 [TBL] [Abstract][Full Text] [Related]
7. Estrogen inhibition of PTH-stimulated osteoclast formation and attachment in vitro: involvement of both PKA and PKC. Liu BY; Wu PW; Bringhurst FR; Wang JT Endocrinology; 2002 Feb; 143(2):627-35. PubMed ID: 11796519 [TBL] [Abstract][Full Text] [Related]
8. Relevance of osteoclast-specific enzyme activities in cell-based in vitro resorption assays. Bernhardt A; Koperski K; Schumacher M; Gelinsky M Eur Cell Mater; 2017 Jan; 33():28-42. PubMed ID: 28098926 [TBL] [Abstract][Full Text] [Related]
9. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells. Kitami S; Tanaka H; Kawato T; Tanabe N; Katono-Tani T; Zhang F; Suzuki N; Yonehara Y; Maeno M Biochimie; 2010 Apr; 92(4):398-404. PubMed ID: 20045440 [TBL] [Abstract][Full Text] [Related]
10. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption. Sasaki T Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416 [TBL] [Abstract][Full Text] [Related]
11. Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro. Cantley MD; Fairlie DP; Bartold PM; Rainsford KD; Le GT; Lucke AJ; Holding CA; Haynes DR J Cell Physiol; 2011 Dec; 226(12):3233-41. PubMed ID: 21344383 [TBL] [Abstract][Full Text] [Related]
12. Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts. Woo JT; Nakagawa H; Notoya M; Yonezawa T; Udagawa N; Lee IS; Ohnishi M; Hagiwara H; Nagai K Biol Pharm Bull; 2004 Apr; 27(4):504-9. PubMed ID: 15056855 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts. Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352 [TBL] [Abstract][Full Text] [Related]
14. Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells. Wei P; Jiao L; Qin LP; Yan F; Han T; Zhang QY Zhong Xi Yi Jie He Xue Bao; 2009 Apr; 7(4):342-8. PubMed ID: 19361364 [TBL] [Abstract][Full Text] [Related]
15. Osteoprotegerin influences the bone resorption activity of osteoclasts. Fu YX; Gu JH; Zhang YR; Tong XS; Zhao HY; Yuan Y; Liu XZ; Bian JC; Liu ZP Int J Mol Med; 2013 Jun; 31(6):1411-7. PubMed ID: 23563320 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the classical NF-kappaB pathway prevents osteoclast bone-resorbing activity. Soysa NS; Alles N; Shimokawa H; Jimi E; Aoki K; Ohya K J Bone Miner Metab; 2009; 27(2):131-9. PubMed ID: 19172225 [TBL] [Abstract][Full Text] [Related]
17. Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-{kappa}B and c-Fms. Granholm S; Lundberg P; Lerner UH J Endocrinol; 2007 Dec; 195(3):415-27. PubMed ID: 18000304 [TBL] [Abstract][Full Text] [Related]
18. Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures. Ikegame M; Rakopoulos M; Martin TJ; Moseley JM; Findlay DM J Bone Miner Res; 1996 Apr; 11(4):456-65. PubMed ID: 8992876 [TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of 8-prenylnaringenin on osteoclastogensis of bone marrow cells and bone resorption activity]. Lü X; Zhou Y; Chen KM; Zhao Z; Zhou J; Ma XN Yao Xue Xue Bao; 2013 Mar; 48(3):347-51. PubMed ID: 23724646 [TBL] [Abstract][Full Text] [Related]
20. Ultrastructural study of the root dentine surface resuming resorption on human deciduous teeth. Domon T; Osanai M; Yawaka Y; Suzuki R; Takahashi S; Yamamoto T; Wakita M Ann Anat; 2000 Mar; 182(2):175-84. PubMed ID: 10755185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]